secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001493152-23-025290
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 3.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AgeX Therapeutics exchanges $36M debt for preferred stock to regain NYSE compliance
--------------------------------------------------------------------------------

- Issued 211,600 Series A and 148,400 Series B preferred shares to Juvenescence in exchange for canceling $36M of debt.
- Debt exchange aims to bring AgeX stockholders' equity above $6M; pro forma equity improves from -$20M to ~$16M as of March 31, 2023.
- Each preferred share convertible into common at $0.72/share; conversion subject to 19.9% and 50% caps unless stockholder approval obtained.
- Preferred stock carries no dividends, liquidation preference over common, and limited voting rights.
- Closing expected July 25, 2023, subject to NYSE American approval and filing of certificates of designation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223025290/0001493152-23-025290-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000149315223025290/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-025290

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer